John Quiring

1.9k total citations
24 papers, 633 citations indexed

About

John Quiring is a scholar working on Physiology, Infectious Diseases and Epidemiology. According to data from OpenAlex, John Quiring has authored 24 papers receiving a total of 633 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Physiology, 5 papers in Infectious Diseases and 4 papers in Epidemiology. Recurrent topics in John Quiring's work include Sympathectomy and Hyperhidrosis Treatments (7 papers), Nail Diseases and Treatments (4 papers) and Antifungal resistance and susceptibility (3 papers). John Quiring is often cited by papers focused on Sympathectomy and Hyperhidrosis Treatments (7 papers), Nail Diseases and Treatments (4 papers) and Antifungal resistance and susceptibility (3 papers). John Quiring collaborates with scholars based in United States, Germany and Canada. John Quiring's co-authors include Nicholas S Hopkinson, Zaid Zoumot, Ewen Ross, Pallav L. Shah, Stephen Bicknell, Suveer Singh, Samuel V. Kemp, Richard B. Lipton, James V. Sorrentino and Dee Anna Glaser and has published in prestigious journals such as Journal of Clinical Oncology, PEDIATRICS and Journal of the American Academy of Dermatology.

In The Last Decade

John Quiring

23 papers receiving 598 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John Quiring United States 14 198 176 91 76 76 24 633
Mohammad Ehlayel Qatar 12 56 0.3× 158 0.9× 70 0.8× 144 1.9× 62 0.8× 24 570
Steven Wang United States 12 46 0.2× 55 0.3× 154 1.7× 15 0.2× 41 0.5× 23 555
Moses Tar United States 17 30 0.2× 111 0.6× 250 2.7× 19 0.3× 10 0.1× 28 702
Alastair Kerr United Kingdom 12 77 0.4× 166 0.9× 28 0.3× 67 0.9× 483 6.4× 22 808
Philip Lieberman United States 15 101 0.5× 557 3.2× 15 0.2× 84 1.1× 270 3.6× 18 1.6k
Edmond Sabo Israel 6 29 0.1× 74 0.4× 15 0.2× 16 0.2× 47 0.6× 8 410
Ulrich Amon Germany 17 30 0.2× 235 1.3× 27 0.3× 79 1.0× 330 4.3× 55 911
Beata Bergler‐Czop Poland 15 23 0.1× 53 0.3× 36 0.4× 134 1.8× 424 5.6× 119 833
S. Fernández Spain 12 38 0.2× 119 0.7× 45 0.5× 15 0.2× 44 0.6× 27 428
Vicki Evans Australia 11 21 0.1× 94 0.5× 13 0.1× 44 0.6× 248 3.3× 24 1.6k

Countries citing papers authored by John Quiring

Since Specialization
Citations

This map shows the geographic impact of John Quiring's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Quiring with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Quiring more than expected).

Fields of papers citing papers by John Quiring

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Quiring. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Quiring. The network helps show where John Quiring may publish in the future.

Co-authorship network of co-authors of John Quiring

This figure shows the co-authorship network connecting the top 25 collaborators of John Quiring. A scholar is included among the top collaborators of John Quiring based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Quiring. John Quiring is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Glaser, Dee Anna, Adelaide A. Hebert, Alexander Nast, et al.. (2019). A 44-Week Open-Label Study Evaluating Safety and Efficacy of Topical Glycopyrronium Tosylate in Patients with Primary Axillary Hyperhidrosis. American Journal of Clinical Dermatology. 20(4). 593–604. 21 indexed citations
2.
Glaser, Dee Anna, Adelaide A. Hebert, Alexander Nast, et al.. (2018). Topical glycopyrronium tosylate for the treatment of primary axillary hyperhidrosis: Results from the ATMOS-1 and ATMOS-2 phase 3 randomized controlled trials. Journal of the American Academy of Dermatology. 80(1). 128–138.e2. 46 indexed citations
3.
Pariser, David M., Adelaide A. Hebert, Janice Drew, et al.. (2018). Topical Glycopyrronium Tosylate for the Treatment of Primary Axillary Hyperhidrosis: Patient-Reported Outcomes from the ATMOS-1 and ATMOS-2 Phase III Randomized Controlled Trials. American Journal of Clinical Dermatology. 20(1). 135–145. 25 indexed citations
4.
Glaser, Dee Anna, Adelaide A. Hebert, Alexander Nast, et al.. (2018). Open-Label Study (ARIDO) Evaluating Long-Term Safety of Topical Glycopyrronium Tosylate (GT) in Patients with Primary Axillary Hyperhydrosis. SKIN The Journal of Cutaneous Medicine. 2. S40–S40.
5.
Glaser, Dee Anna, Adelaide A. Hebert, Alexander Nast, et al.. (2017). Open-Label Study (ARIDO) Evaluating Long-Term Safety of Topical Glycopyrronium Tosylate (GT) in Patients with Axillary Hyperhidrosis. SKIN The Journal of Cutaneous Medicine. 1. s95–s95. 2 indexed citations
6.
Shah, Pallav L., Zaid Zoumot, Suveer Singh, et al.. (2013). Endobronchial coils for the treatment of severe emphysema with hyperinflation (RESET): a randomised controlled trial. The Lancet Respiratory Medicine. 1(3). 233–240. 159 indexed citations
7.
Maddin, Stuart, et al.. (2013). Randomized, placebo-controlled, phase 3 study of itraconazole for the treatment of onychomycosis.. PubMed. 12(7). 758–63. 14 indexed citations
10.
Stough, Dow B., et al.. (2009). Efficacy and Safety of Spinosad and Permethrin Creme Rinses for Pediculosis Capitis (Head Lice). PEDIATRICS. 124(3). e389–e395. 49 indexed citations
11.
Faergemann, Jan, et al.. (2009). A double-blind, randomized, placebo-controlled, dose-finding study of oral pramiconazole in the treatment of pityriasis versicolor. Journal of the American Academy of Dermatology. 61(6). 971–976. 10 indexed citations
12.
Webster, Guy, et al.. (2009). A combined analysis of 2 randomized clinical studies of tretinoin gel 0.05% for the treatment of acne.. PubMed. 83(3). 146–54. 19 indexed citations
13.
Spraker, Mary K., et al.. (2006). Topical miconazole nitrate ointment in the treatment of diaper dermatitis complicated by candidiasis.. PubMed. 77(2). 113–20. 20 indexed citations
14.
Lipton, Richard B., Jerome Goldstein, Jeffrey S. Baggish, et al.. (2005). Aspirin Is Efficacious for the Treatment of Acute Migraine. Headache The Journal of Head and Face Pain. 45(4). 283–292. 65 indexed citations
15.
Kraft, Walter K., et al.. (2003). The Pharmacokinetics of Nebulized Nanocrystal Budesonide Suspension in Healthy Volunteers. The Journal of Clinical Pharmacology. 44(1). 67–72. 51 indexed citations
16.
Glover, Elbert D., Scott J. Leischow, Stephen I. Rennard, et al.. (1998). A Smoking Cessation Trial with Lobeline Sulfate: A Pilot Study. 22(1). 62–74. 4 indexed citations
17.
Quiring, John, et al.. (1985). Ethnic Bias in California Courts: A Case Study of Chicano and Anglo Felony Defendants. Sociological Inquiry. 55(1). 83–96. 6 indexed citations
18.
Quiring, John, et al.. (1976). The influence of aspirin on gastrointestinal microbleeding in dogs with gastric ulcers. Digestive Diseases and Sciences. 21(12). 1029–1032. 1 indexed citations
19.
Quiring, John. (1972). The autotutorial approach.. PubMed. 21(4). 332–7. 4 indexed citations
20.
Quiring, John. (1972). Coherent Odds and Bayesian Odds. University of Minnesota Digital Conservancy (University of Minnesota). 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026